Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).

Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab. 1994 Jan; 78(1):188-96.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.